Oncolix Inc. (fka ONCX)

[steadyhand]

Namtae,

Sorry but you are wrong about that:

The home page of the website clearly states:

"Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat."

Efficacy has been mentioned in context to the dosed patients so far. However any efficacy results are 2nd to the question of safety in phase 1. And for that matter it was the lowest dose group. They will go higher until a breakpoint of efficacy vs safety is found.

We do not however know what that means... A complete response would be very unlikely in a low dose phase 1 study (all tumors gone). This likely means that the patients did have some benefit though.

Perhaps Redman will unload exactly what the results were after ticker change and uplist.

I applaud you not wanting to read to much into it. We shouldn't. But Redman has indicated that the results were good (efficacy and safety) to many people via email and other public disclosures.